Develops, sells and supports robotic and helical radiation therapy systems, treatment-planning software and related services for hospitals and cancer treatment facilities.
10-K for FY2026, filed Aug 27, 2026Accuray Incorporated is a radiation therapy company that develops, manufactures, sells and supports treatment delivery, planning, imaging…View ↗
Our CyberKnife platform and helical portfolio, including Accuray Stellar, Radixact, Accuray Helix and Tomo C Systems, where available, are…View ↗
Our products include robotic and helical radiation delivery systems, supported by treatment planning, imaging, motion management, adaptive…View ↗
In the United States, we primarily market directly to customers, including hospitals and stand-alone treatment facilities, through our…View ↗
Hospitals and other treatment facilities pay for radiation therapy systems, generally when the systems are shipped; the company earns service revenue over time from support, maintenance and other service arrangements.
10-K for FY2026, filed Aug 27, 2026The Company expects to recognize as revenue the significant majority of the additional $11.3 million of remaining performance obligations…View ↗
Additionally, the Company typically recognizes revenue at a point in time for product revenue and recognizes revenue over time for service…View ↗
Deferred revenue represents contract liabilities for amounts billed or collected from customers for which the related performance…View ↗
10-K for FY2026, filed Aug 27, 2026
FY2026 revenue by product or service ↗$401.9M
10-K for FY2026, filed Aug 27, 2026
$401.9M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2026, filed Aug 27, 2026 |
43%
FY2023: 52%
|
Product, FY2026
$172.7M Sources
|
Sold outright |
|
Service
Recurring
10-K for FY2026, filed Aug 27, 2026 |
57%
FY2023: 48%
|
Service, FY2026
$229.2M Sources
|
Recurring |
Hospitals and stand-alone treatment facilities are primarily served directly in the United States, with sales agents and group purchasing organizations also involved. Outside the United States, Accuray sells directly and through distributors and sales agents.
10-K for FY2026, filed Aug 27, 2026In the United States, we primarily market directly to customers, including hospitals and stand-alone treatment facilities, through our…View ↗
In direct sales markets, we employ a combination of territory sales managers, product specialists, training specialists and marketing…View ↗
Under our standard distribution agreement, we generally appoint a distributor for a specific country. We typically also retain the right to…View ↗
10-K for FY2026, filed Aug 27, 2026
For the years ended June 30, 2026, and 2025, the JV represented 16% and 26%, respectively, of the Company’s total net revenue. For the…View ↗
No. It lost $49.2M in FY2026.
10-K for FY2026, filed Aug 27, 2026
−$26.4MView ↗
10-K for FY2026, filed Aug 27, 2026
−$49.2MView ↗
10-K for FY2026, filed Aug 27, 2026
−$12.8MView ↗
Flat. Revenue was $401.9M in FY2026, about the same as the $429.9M of FY2022.
Broader helical product range
The latest report describes a broader helical portfolio, adding Accuray Stellar, Accuray Helix and Tomo C Systems alongside Radixact; the older report described the CyberKnife and TomoTherapy platforms, including Radixact.
10-K for FY2023, filed Sep 7, 2023 10-K for FY2026, filed Aug 27, 2026
More integrated service offerings
The latest report describes an expansion beyond traditional maintenance and support toward integrated services such as remote diagnostics, workflow optimization, analytics and clinical support; the older report describes customer support, installation, training and other professional services.
10-K for FY2023, filed Sep 7, 2023 10-K for FY2026, filed Aug 27, 2026Our innovative technologies, the CyberKnife® and TomoTherapy® platforms, including the Radixact® System, our next generation TomoTherapy…View ↗
Expand services and solutions to drive recurring revenue and customer value. We are expanding our services business beyond traditional…View ↗
Competes with Varian Medical Systems, Elekta AB, RefleXion Medical, ZAP® Surgical Systems, and United Imaging Healthcare
10-K for FY2026, filed Aug 27, 2026New product sales in this competitive market are primarily dominated by two companies: Varian Medical Systems, Inc, a Siemens Healthineers…View ↗
Loading...